Nektar Therapeutics (BMV:NKTR)
Mexico
· Delayed Price · Currency is MXN 165.00
0.00 (0.00%)
At close: Jun 17, 2025
Nektar Therapeutics Revenue
Nektar Therapeutics had revenue of $10.46M USD in the quarter ending March 31, 2025, a decrease of -51.66%. This brings the company's revenue in the last twelve months to $87.25M, down -3.24% year-over-year. In the year 2024, Nektar Therapeutics had annual revenue of $98.43M with 9.22% growth.
Revenue (ttm)
$87.25M
Revenue Growth
-3.24%
P/S Ratio
1.14
Revenue / Employee
$1.43M
Employees
61
Market Cap
2.03B MXN
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 98.43M | 8.31M | 9.22% |
| Dec 31, 2023 | 90.12M | -1.93M | -2.10% |
| Dec 31, 2022 | 92.06M | -9.85M | -9.67% |
| Dec 31, 2021 | 101.91M | -51.01M | -33.36% |
| Dec 31, 2020 | 152.92M | 38.30M | 33.41% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Wal-Mart de México | 972.31B |
| Grupo Financiero Banorte | 131.20B |
| Arca Continental | 245.87B |
| Industrias Peñoles | 144.13B |
| GMéxico Transportes | 61.50B |
| FIBRA Prologis | 11.79B |
| Fibra UNO | 29.47B |
| Promotora y Operadora de Infraestructura, S. A. B. de C. V. | 18.37B |